A newly surfaced internal memo from the U.S. Food and Drug Administration (FDA) has sparked debate after chief medical and scientific officer Vinay Prasad stated that COVID-19 vaccinations may have contributed to at least 10 cases of fatal heart inflammation in children. According to the memo, seen by Reuters, Prasad said the staff’s preliminary review suggested “likely, probable, or possible” vaccine attribution in these deaths. He described the findings as significant, noting it would mark the first time the FDA acknowledged potential fatal vaccine-related cases in American children.
The analysis reviewed 96 child deaths reported between 2021 and 2024. While it did not identify the children’s underlying medical conditions or the vaccine manufacturers involved, Prasad said that the early assessment found no fewer than 10 cases potentially linked to COVID-19 vaccination. He added that examining deaths involving children aged 7 to 16 was especially difficult.
Health Secretary Robert F. Kennedy Jr. has recently shifted U.S. vaccine policy, restricting access to COVID-19 vaccines to individuals 65 and older and those with certain conditions. Kennedy, long known for his skepticism toward vaccines, has criticized past vaccine policies promoted under both the Trump and Biden administrations.
Experts have urged caution in interpreting the memo. The FDA’s assessment has not been peer-reviewed or published in a medical journal, and critics—including UC Law San Francisco professor Dorit Reiss—argue that policy changes should not stem from unpublished investigations. Reiss also noted Prasad is not a vaccine specialist.
Despite concerns raised in the memo, FDA Commissioner Marty Makary emphasized that COVID-19 vaccines were highly effective for older adults, especially when matched to circulating variants. Recent research also supports the benefits of updated vaccines in reducing severe illness and hospitalization among high-risk groups.
CDC data shows 1,071 U.S. children aged 5 to 18 died from COVID-19 between early 2020 and mid-2023. Prasad argued that it remains unclear how vaccination influenced those outcomes, stating that voluntary reporting and unknown prevention metrics complicate comparisons.
The memo is expected to fuel continued discussion ahead of an upcoming CDC vaccine committee meeting.


Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
Brazil Arrests Former Peruvian Foreign Minister Augusto Blacker Miller in International Fraud Case
Australia Enforces World-First Social Media Age Limit as Global Regulation Looms
Belarus Frees 123 Political Prisoners in U.S.-Brokered Deal Over Sanctions
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
Novo Nordisk Appoints Greg Miley to Lead Corporate Affairs Amid U.S. Drug Pricing Pressure
California, 18 States Sue to Block Trump’s $100,000 H-1B Visa Fee
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
Trump Criticizes Insurers as Debate Over Extending Obamacare Subsidies Intensifies
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
Trump Administration Fuel-Efficiency Rollback Could Raise Long-Term Costs for U.S. Drivers
Russian Drone Attack Hits Turkish Cargo Ship Carrying Sunflower Oil to Egypt, Ukraine Says
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Indonesia–U.S. Tariff Talks Near Completion as Both Sides Push for Year-End Deal
Trump Signals Conditional Push for Ukraine Peace Talks as Frustration Mounts 



